Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
09/23/2010 | US20100239552 Combination Therapies for Treating Metabolic Disorders |
09/23/2010 | US20100239538 Compositions comprising vascular and myocyte progenitor cells and methods of their use |
09/23/2010 | US20100239523 Tlr modulators and methods for using the same |
09/23/2010 | US20100239520 Organic compounds |
09/23/2010 | US20100239507 Surface modified aerosol particles, a method and apparatus for production thereof and powders and dispersions containing said particles |
09/23/2010 | US20100236958 Radiopharmaceutical composition |
09/23/2010 | DE102010001064A1 Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung Substituted 2-acetamido-5-aryl-1,2,4-triazolones and their use |
09/23/2010 | DE102009014165A1 Product, useful e.g. to treat and prevent disorders or diseases of lungs, cardiovascular and neuronal system caused by inhalation of tobacco smoke and respiratory diseases e.g. asthma, bronchitis and chronic cough, comprises cobalamin |
09/23/2010 | DE102009013642A1 Substituierte Phenylalaninderivate und deren Verwendung Substituted phenylalanine derivatives and the use thereof |
09/23/2010 | CA2835771A1 Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
09/23/2010 | CA2793800A1 Peptides that inhibit angiotensin converting enzyme and peptides with antioxidant activity purified from ovotransferrin and methods of producing and using the same |
09/23/2010 | CA2755726A1 A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment |
09/23/2010 | CA2755697A1 Amide derivative |
09/23/2010 | CA2755641A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof |
09/23/2010 | CA2755590A1 Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiency |
09/23/2010 | CA2755509A1 Agents and methods for tissue repair and regeneration |
09/23/2010 | CA2754509A1 Novel anti-inflammatory agents |
09/22/2010 | EP2229955A1 Fibroblast growth factor receptor-1 inhibitors and methods of treatment using the same |
09/22/2010 | EP2229942A1 2-Aryl-propionic acids and pharmaceutical compositions containing them |
09/22/2010 | EP2229824A1 Covalent milk protein/isothiocyanate complexes |
09/22/2010 | EP2229451A1 Materials and methods for inhibiting mammalian s-nitrosoglutathione reductase |
09/22/2010 | EP2229405A1 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
09/22/2010 | EP2229368A1 Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
09/22/2010 | EP2229173A1 Oxazolidinones for the treatment and/or prophylaxis of heart failure |
09/22/2010 | EP2229172A1 Triazolo [4,5-d] pyrimidine compounds for treatment of abdominal aortic aneurysms |
09/22/2010 | EP2229167A1 Mineralocorticoid receptor modulators |
09/22/2010 | EP2229165A1 Anti-glycation properties of asicatic acid and madecassic acid |
09/22/2010 | EP2229056A1 Compositions for protection against superficial vasodilator flush syndrome, and methods of use |
09/22/2010 | EP1896477B1 Aspartyl protease inhibitors |
09/22/2010 | EP1890721B1 Compositions and methods for treating cardiac conditions |
09/22/2010 | EP1836163B1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
09/22/2010 | EP1809271B9 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
09/22/2010 | EP1436313B1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
09/22/2010 | EP1335938B1 Apolipoprotein construct |
09/22/2010 | CN201585758U Therapeutic massage mat adopting traditional Chinese medicine magnetotherapy |
09/22/2010 | CN201585460U Multifunctional pillow health care cap |
09/22/2010 | CN1970015B Enzymatic extraction method of pawpaw polyphenol |
09/22/2010 | CN1943755B A Chinese traditional medicinal composition for treatment of hypertension and its preparation method |
09/22/2010 | CN1943726B A Chinese traditional medicinal composition for treatment of ischemic apoplexy and its preparation method |
09/22/2010 | CN1813782B Composition of ginkgo leaf extract and dipyridamole, medicine containing same and preparing method thereof |
09/22/2010 | CN1612746B Use of HEPCIDIN as a regulator of iron homeostasis |
09/22/2010 | CN101842390A Antibodies against RAMP3 |
09/22/2010 | CN101842119A Diagnostic and therapeutic methods and compositions for cardiovascular disease |
09/22/2010 | CN101842108A Use of g-csf for the treatment of stroke |
09/22/2010 | CN101842096A Film-coated preparation |
09/22/2010 | CN101838329A Anti-angiogenesis fusion protein |
09/22/2010 | CN101838323A Anti-platelet thrombolysin and preparation method thereof |
09/22/2010 | CN101838263A Benzimidazole derivative with cardiovascular activity and preparing method and application thereof |
09/22/2010 | CN101838261A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
09/22/2010 | CN101838253A Preparation method of ligustilide and butylidene phthalide |
09/22/2010 | CN101838213A Method for preparing laminine and pharmaceutically acceptable salts thereof |
09/22/2010 | CN101837127A Medical use of inhibitors of glutaminyl and glutamate cyclases |
09/22/2010 | CN101837114A Medicinal composition for treating palpitation |
09/22/2010 | CN101837102A Traditional Chinese medicine anther cap for controlling cardiovascular and cerebrovascular diseases, preparing method and quality control method thereof |
09/22/2010 | CN101837101A Traditional Chinese medicine anther cap for controlling cardiovascular and cerebrovascular diseases, preparing method and quality control method thereof |
09/22/2010 | CN101837092A Chinese medicament for curing cardiopathy |
09/22/2010 | CN101837090A Chinese medicinal composition for curing cardiac neurosis |
09/22/2010 | CN101837069A Method for preparing eggplant wine |
09/22/2010 | CN101837060A Chinese medicine for adjusting hypertension, hyperlipidemia and hyperglycemia |
09/22/2010 | CN101837059A Method for preparing apple polyphenol |
09/22/2010 | CN101837056A Foot-bath effervescent tablet for improving blood stasis-type thoracic obstruction caused by qi deficiency |
09/22/2010 | CN101837051A New rhodobryum roseum tablet medicament composition |
09/22/2010 | CN101837038A Novel brain-soothing soft capsule and process preparation method thereof |
09/22/2010 | CN101837034A Method for extracting radix achyranthis bidentatae saponin |
09/22/2010 | CN101837032A Blueberry anthocyanin oral solution |
09/22/2010 | CN101837007A Medicinal composition for curing hemorrhoids and preparation method thereof |
09/22/2010 | CN101836999A Medicinal composition for curing cardiovascular diseases |
09/22/2010 | CN101836997A Glycerol/fructose composite and preparation method thereof |
09/22/2010 | CN101836993A Application of 2,3-dihydrogen-3-hydroxymethyl-6-amino-[1,4]-benzoxazine in preparing medicaments for inducing embryonic stem cells to differentiate towards vascular endothelial cells |
09/22/2010 | CN101836981A Compound valsartan benzenesulfonic acid amlodipine medicament composition and new preparation method thereof |
09/22/2010 | CN101836966A Agomelatine-containing orally disintegrating tablet |
09/22/2010 | CN101836963A Medicinal application preparation for curing hypertension |
09/22/2010 | CN101836810A Blood-pressure-reducing pillow |
09/22/2010 | CN101361719B Bromhexine hydrochloric acid orally disintegrating tablet production method |
09/22/2010 | CN101234089B Alkaline fibroblast growth factor liposome vaccine and preparation method and application thereof |
09/22/2010 | CN101121002B Chinese preparatory medicine for treating high blood pressure diseases |
09/21/2010 | US7799913 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
09/21/2010 | US7799833 System and method for the pretreatment of the endplates of an intervertebral disc |
09/21/2010 | US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis |
09/21/2010 | US7799795 chemokine receptor modulators such as N-(1-(3-(4-cyanophenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)ethyl)-N-(2-(ethylsulfonyl)ethyl)-2-(4-fluoro-3-(trifluoromethyl)phenyl)-acetamide, used for the treatment of asthma, allergic and autoimmune diseases |
09/21/2010 | US7799794 Treatment for cardiovascular disease |
09/21/2010 | US7799787 pyridazine derivatives such as N-(2-Cyclopropylethyl)-6-{4-[2-(trifluoromethyl)phenoxy]piperidin-1-yl}pyridazine-3-carboxamide, useful for the prevention and treatment of dyslipidemia, obesity, diabetes, syndrome X, insulin resistance, fatty liver, cancer, cardiovascular and nervous system disorders |
09/21/2010 | US7799775 Pyrimidine derivatives |
09/21/2010 | US7799771 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol acetate; FDA Orange book listed patent for estradiol acetate |
09/21/2010 | US7799763 Muscle-strengthening drugs and anti-inflammatory drugs |
09/21/2010 | US7799760 Use of pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention |
09/21/2010 | US7799349 Isolating autologous mononuclear cells and transplanting locally into injured tissue |
09/21/2010 | US7799335 Differential delivery of nitric oxide |
09/21/2010 | CA2473892C Novel quinoline derivatives |
09/21/2010 | CA2449521C Pharmaceutical formulation, its use, and method for its manufacture |
09/21/2010 | CA2445068C Azo compounds for type i phototherapy |
09/21/2010 | CA2440559C Novel non-imidazole compounds |
09/21/2010 | CA2438593C Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
09/21/2010 | CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
09/21/2010 | CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them |
09/21/2010 | CA2434178C Substituted amine derivatives and methods of use |
09/21/2010 | CA2429308C Novel lactam-substituted pyrazolopyridine derivatives |
09/21/2010 | CA2420568C Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases |
09/21/2010 | CA2417148C Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
09/21/2010 | CA2401502C Carboxylic acid derivatives as ip antagonists |